Neffy®（肾上腺素鼻喷雾剂）已在加拿大获得批准，成为该国首个且唯一用于治疗过敏反应（包括危及生命的过敏性休克）的无针急救疗法。这一批准标志着严重过敏反应应急管理领域的重大突破，为患者提供了一种无需注射的便捷替代方案。
Neffy®（肾上腺素鼻喷雾剂）已在加拿大获得批准，成为该国首个且唯一用于治疗过敏反应（包括危及生命的过敏性休克）的无针急救疗法。这一批准标志着严重过敏反应应急管理领域的重大突破，为患者提供了一种无需注射的便捷替代方案。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.